Breast Cancer

Radiation for older women with breast cancer

More than half of older women with early stage breast cancer receive more radiation therapy than what might be medically necessary and following evidence-based guidelines for radiation would significantly reduce costs, according to a...

New guidelines for managing care of breast cancer survivors

The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer survivors and their primary care providers better manage their long-term...

False-positive mammograms may indicate increased risk for breast cancer later in life

Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after the false-positive result, according to a study in Cancer Epidemiology,...

Older women with breast cancer less likely to benefit from chemotherapy

For women over the age of 80 who have breast cancer, the chances of survival due to chemotherapy are significantly lower, according to a study in the Journal of American Geriatrics Society. Read more and...

FDA approves Ibrance for postmenopausal women with metastatic breast cancer

On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.

Breast cancer care gets personal

Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss targeted therapy for breast cancer. 4. Describe novel therapies for breast cancer. Purpose/goal: To provide...

The elusive cure

Supporting breast cancer research and screening can help us get another step closer to curing this disease.

Make your health a priority.

May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.

FDA expands Zytiga’s use for late-stage breast cancer

On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate cancer before receiving chemotherapy. Read more.

Study: Delaying childbirth may reduce risk of aggressive form of breast cancer

Younger women who wait at least 15 years after their first menstrual period to give birth to their first child may reduce their risk of an aggressive form of breast cancer by up to...

Anastrozole and fulvestrant combination effective in metastatic breast cancer

The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women, according to a study in...

Mindfulness program benefits early-stage breast cancer survivors

A mindfulness-based stress reduction program significantly improved physiological and psychological outcomes among early-stage breast cancer survivors according to a study in Western Journal of Nursing Research. Read more.

Persistent fatigue after breast cancer may speed aging

Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients seem as much as 20 years older. Read more at...